{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:33:43Z","timestamp":1792157623287,"version":"4.4.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T00:00:00Z","timestamp":1380412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s11926-013-0376-5","type":"journal-article","created":{"date-parts":[[2013,9,28]],"date-time":"2013-09-28T09:06:38Z","timestamp":1380359198000},"source":"Crossref","is-referenced-by-count":22,"title":["Granuloma in ANCA-Associated Vasculitides: Another Reason to Distinguish Between Syndromes?"],"prefix":"10.1007","volume":"15","author":[{"given":"Antje","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstanze","family":"Holl-Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,29]]},"reference":[{"key":"376_CR1","doi-asserted-by":"crossref","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","DOI":"10.1002\/art.37715"},{"key":"376_CR2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.lpm.2013.01.003","volume":"42","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ. Pathogenesis of ANCA-associated vasculitis: observations, theories and speculations. La Presse Med Q Med Rev. 2013;42:493\u20138.","journal-title":"La Presse Med Q Med Rev"},{"key":"376_CR3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","volume":"66","author":"B Hellmich","year":"2007","unstructured":"Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, et al. EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007;66:605\u201317.","journal-title":"Ann Rheum Dis"},{"key":"376_CR4","first-page":"344","volume":"16","author":"A Berden","year":"2012","unstructured":"Berden A, G\u00f6\u00e7eroglu A, Jayne D, Luqmani R, Rasmussen N, Bruijn JA, et al. Diagnosis and management of ANCA associated vasculitis. Br Med J. 2012;16:344.","journal-title":"Br Med J"},{"key":"376_CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11926-012-0284-0","volume":"14","author":"D Geetha","year":"2012","unstructured":"Geetha D, Seo P. Advances in therapy for ANCA-associated vasculitis. Curr Rheumatol Rep. 2012;14:509\u201315.","journal-title":"Curr Rheumatol Rep"},{"key":"376_CR6","unstructured":"Sch\u00f6nermarck U, Gross WL, de Groot K. Treatment of ANCA-associated vasculitis. Nat Rev Nephrol. In press."},{"key":"376_CR7","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"MA Little","year":"2010","unstructured":"Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, et al. Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis. 2010;69:1036\u201343.","journal-title":"Ann Rheum Dis"},{"key":"376_CR8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70:488\u201394.","journal-title":"Ann Rheum Dis"},{"key":"376_CR9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrrheum.2012.188","volume":"9","author":"R Luqmani","year":"2013","unstructured":"Luqmani R. Maintenance of clinical remission in ANCA-associated vasculitis. Nat Rev Rheumatol. 2013;9:127\u201332.","journal-title":"Nat Rev Rheumatol"},{"key":"376_CR10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2796.2008.02060.x","volume":"265","author":"P Eriksson","year":"2009","unstructured":"Eriksson P, Jacobsson L, Lindell A, Nilsson JA, Skogh T. Improved outcome in Wegener\u2019s granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in 2 cohorts. J Intern Med. 2009;265:496\u2013506.","journal-title":"J Intern Med"},{"key":"376_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/art.27763","volume":"63","author":"JU Holle","year":"2011","unstructured":"Holle JU, Gross WL, Latza U, N\u00f6lle B, Ambrosch P, Heller M, et al. Improved outcome in 445 patients with Wegener\u2019s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum. 2011;63:257\u201366.","journal-title":"Arthritis Rheum"},{"key":"376_CR12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-143-9-200511010-00012","volume":"143","author":"GS Hoffman","year":"2005","unstructured":"Hoffman GS, Langford CA. Are there different forms of life in the antineutrophil cytoplasmic antibody universe? Ann Intern Med. 2005;143:683\u20135.","journal-title":"Ann Intern Med"},{"key":"376_CR13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMp048338","volume":"352","author":"PA Bacon","year":"2005","unstructured":"Bacon PA. The spectrum of Wegener\u2019s granulomatosis and disease relapse. N Engl J Med. 2005;352:330\u20132.","journal-title":"N Engl J Med"},{"key":"376_CR14","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/rheumatology\/kes230","volume":"51","author":"RA Watts","year":"2012","unstructured":"Watts RA, Scott DG. ANCA vasculitis: to lump or split? Why we should study MPA and GPA separately. Rheumatology. 2012;51:2115\u20137.","journal-title":"Rheumatology"},{"key":"376_CR15","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2013-203255","volume":"72","author":"A Millet","year":"2013","unstructured":"Millet A, Pederzoli-Ribeil M, Guillevin L, Witko-Sarsat V, Mouthon L. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Ann Rheum Dis. 2013;72:1273\u20139.","journal-title":"Ann Rheum Dis"},{"key":"376_CR16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nrneph.2012.261","volume":"9","author":"FC Fervenza","year":"2013","unstructured":"Fervenza FC, Specks U. Vasculitis: refining phenotypes in ANCA-associated vasculitis. Nat Rev Nephrol. 2013;9:6\u20138.","journal-title":"Nat Rev Nephrol"},{"key":"376_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrrheum.2011.218","volume":"8","author":"S Gadola","year":"2012","unstructured":"Gadola S, Gross WL. Vasculitis in 2011: the renaissance of granulomatous inflammation in AAV. Nat Rev Rheumatol. 2012;8:74\u20136.","journal-title":"Nat Rev Rheumatol"},{"key":"376_CR18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.lpm.2013.01.041","volume":"42","author":"JU Holle","year":"2013","unstructured":"Holle JU. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes? La Presse Med Q Med Rev. 2013;42:616\u20139.","journal-title":"La Presse Med Q Med Rev"},{"key":"376_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","volume":"335","author":"CA Stegeman","year":"1996","unstructured":"Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis. N Engl J Med. 1996;335:16\u201320.","journal-title":"N Engl J Med"},{"key":"376_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.qjmed.a030133","volume":"89","author":"E Reinhold-Keller","year":"1996","unstructured":"Reinhold-Keller E, De Groot K, Rudert H, N\u00f6lle B, Heller M, Gross WL. Response to trimethoprim\/sulfamethoxazole in Wegener\u2019s granulomatosis depends on the phase of the disease. Q J Med. 1996;89:15\u201323.","journal-title":"Q J Med"},{"key":"376_CR21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2012.08.006","volume":"12","author":"RA Sinico","year":"2013","unstructured":"Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev. 2013;12:477\u201382.","journal-title":"Autoimmun Rev"},{"key":"376_CR22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.lpm.2013.02.308","volume":"42","author":"JF Cordier","year":"2013","unstructured":"Cordier JF, Cottin V, Guillevin L, Bel E, Bottero P, Dalhoff K, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss). La Presse Med Q Med Rev. 2013;42:507\u201310.","journal-title":"La Presse Med Q Med Rev"},{"key":"376_CR23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","volume":"72","author":"F Moosig","year":"2013","unstructured":"Moosig F, Bremer JP, Hellmich B, Holle JU, Holl-Ulrich K, Laudien M, et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis. 2013;72:1011\u20137.","journal-title":"Ann Rheum Dis"},{"key":"376_CR24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/rheumatology\/kes420","volume":"52","author":"F Moosig","year":"2013","unstructured":"Moosig F, Richardt G, Gross WL. A fatal attraction: eosinophils and the heart. Rheumatology. 2013;52:587\u20139.","journal-title":"Rheumatology"},{"key":"376_CR25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/rheumatology\/kes412","volume":"52","author":"JP Bremer","year":"2013","unstructured":"Bremer JP, Csernok E, Holle J, Gross WL, Moosig F. Getting rid of MPO-ANCA: a matter of disease subtype. Rheumatology. 2013;52:752\u20134.","journal-title":"Rheumatology"},{"key":"376_CR26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/BOR.0b013e3283323538","volume":"22","author":"E Csernok","year":"2010","unstructured":"Csernok E, Lamprecht P, Gross WL. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol. 2010;22:43\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"376_CR27","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1136\/ard.2010.130203","volume":"69","author":"JU Holle","year":"2010","unstructured":"\u2022 Holle JU, Gross WL, Holl-Ulrich K, Ambrosch P, Noelle B, Both M, et al. Prospective long-term follow-up of patients with localised Wegener\u2019s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis. 2010;69:1934\u20139. This is the first study to identify a subset of GPA patients with a persistent variant of localized granulomatous disease.","journal-title":"Ann Rheum Dis"},{"key":"376_CR28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3899\/jrheum.100518","volume":"38","author":"C Pagnoux","year":"2011","unstructured":"\u2022 Pagnoux C, Stubbe M, Lifermann F, Decaux O, Pavic M, B\u00e9rezn\u00e9 A, et al. French Vasculitis Study Group. Wegener\u2019s granulomatosis strictly and persistently localized to one organ is rare: assessment of 16 patients from the French vasculitis study group database. J Rheumatol. 2011;38:475\u20138. This is the second study to identify a subgroup of GPA patients with localized granulomatous disease only.","journal-title":"J Rheumatol"},{"key":"376_CR29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00439-004-1092-z","volume":"114","author":"P Jagiello","year":"2004","unstructured":"Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, et al. New genomic region for Wegener\u2019s granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet. 2004;114:468\u201377.","journal-title":"Hum Genet"},{"key":"376_CR30","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/ard.2007.077693","volume":"67","author":"M Heckmann","year":"2008","unstructured":"Heckmann M, Holle JU, Arning L, Knaup S, Hellmich B, Nothnagel M, et al. The Wegener\u2019s granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann Rheum Dis. 2008;67:972\u20139.","journal-title":"Ann Rheum Dis"},{"key":"376_CR31","doi-asserted-by":"crossref","first-page":"20736","DOI":"10.1073\/pnas.1109227109","volume":"108","author":"JM Kelley","year":"2011","unstructured":"Kelley JM, Monach PA, Ji C, Zhou Y, Wu J, Tanaka S, et al. IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sci. 2011;108:20736\u201341.","journal-title":"Proc Natl Acad Sci"},{"key":"376_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BOR.0b013e3283331151","volume":"22","author":"S Wieczorek","year":"2010","unstructured":"Wieczorek S, Holle JU, Epplen JT. Recent progress in the genetics of Wegener\u2019s granulomatosis and Churg-Strauss syndrome. Curr Opin Rheumatol. 2010;22:8\u201314.","journal-title":"Curr Opin Rheumatol"},{"key":"376_CR33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"\u2022\u2022 Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367:214\u201323. The first GWAS study on ANCA-associated vasculitides provides convincing evidence that risk genes linked to autoantibodies differentiate AAV phenotypes.","journal-title":"N Engl J Med"},{"key":"376_CR34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJMe1203592","volume":"367","author":"M Cid","year":"2012","unstructured":"Cid M. The search for genetic links in ANCA-associated vasculitis and its variants. N Engl J Med. 2012;367:271\u20133.","journal-title":"N Engl J Med"},{"key":"376_CR35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2249.2004.02608.x","volume":"138","author":"K Pieters","year":"2004","unstructured":"Pieters K, Pettersson A, Gullberg U, Hellmark T. The \u2212564 A\/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener\u2019s granulomatosis does not increase the promoter activity. Clin Exp Immunol. 2004;138:266\u201370.","journal-title":"Clin Exp Immunol"},{"key":"376_CR36","doi-asserted-by":"crossref","unstructured":"Xie G, Roshandel D, Sherva R, Monach PA, Lu Y, Kung T, et al. Granulomatosis with polyangiitis (Wegener\u2019s) is associated with HLA-DPB1*04 and SEMA6A gene variants: evidence from a genome-wide analysis. Arthritis Rheum. 2013;65:2457\u201368.","DOI":"10.1002\/art.38036"},{"key":"376_CR37","author":"CA Husmann","year":"2013","unstructured":"Husmann CA, Holle JU, Moosig F, Mueller S, Wilde B, Cohen Tervaert JW, et al. Genetics of toll like receptor 9 in ANCA associated vasculitides. Ann Rheum Dis. 2013. doi: 10.1136\/annrheumdis-2012-202803 .","journal-title":"Ann Rheum Dis"},{"key":"376_CR38","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/ard.2009.108043","volume":"69","author":"PA Lyons","year":"2010","unstructured":"Lyons PA, McKinney EF, Rayner TF, Hatton A, Woffendin HB, Koukoulaki M, et al. Novel transcription signatures identified by transcriptional analysis of separated leukocyte subsets in systemic lupus erythematosus and vasculitis. Ann Rheum Dis. 2010;69:1208\u201313.","journal-title":"Ann Rheum Dis"},{"key":"376_CR39","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.27398","volume":"62","author":"C Cheadle","year":"2010","unstructured":"Cheadle C, Berger AE, Andrade F, James R, Johnson K, Watkins T, et al. Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener\u2019s granulomatosis. Arthritis Rheum. 2010;62:1744\u201354.","journal-title":"Arthritis Rheum"},{"key":"376_CR40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","volume":"143","author":"SL Hogan","year":"2005","unstructured":"Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005;143:621\u201331.","journal-title":"Ann Intern Med"},{"key":"376_CR41","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","volume":"58","author":"C Pagnoux","year":"2008","unstructured":"Pagnoux C, Hogan SL, Chin H, Jennette JC, Falk RJ, Guillevin L, et al. Predictors of treatment resistance and relapse in anti-neutrophil cytoplasmic antibody-associated small vessel vasculitis: comparison of two independent cohorts. Arthritis Rheum. 2008;58:2908\u201318.","journal-title":"Arthritis Rheum"},{"key":"376_CR42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","volume":"64","author":"M Walsh","year":"2012","unstructured":"Walsh M, Flossmann O, Berden A, Westman K, H\u00f6glund P, Stegeman C, et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012;64:542\u20138.","journal-title":"Arthritis Rheum"},{"key":"376_CR43","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","volume":"64","author":"S Lionaki","year":"2012","unstructured":"\u2022 Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides. Arthritis Rheum. 2012;64:3452\u201362. This study reveals that ANCA specificity is superior to clinical classifications (CHCC, EMA) regarding prediction of disease outcome, for example relapse.","journal-title":"Arthritis Rheum"},{"key":"376_CR44","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","volume":"72","author":"A Mahr","year":"2013","unstructured":"Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, H\u00f6glund P, et al. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis. 2013;72:1003\u201310.","journal-title":"Ann Rheum Dis"},{"key":"376_CR45","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","volume":"123","author":"AJ Roth","year":"2013","unstructured":"Roth AJ, Ooi JD, Hess JJ, van Timmeren MM, Berg EA, Poulton CE, et al. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest. 2013;123:1773\u201383.","journal-title":"J Clin Invest"},{"key":"376_CR46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/BOR.0b013e328333390b","volume":"22","author":"C Pagnoux","year":"2010","unstructured":"Pagnoux C, Guillevin L. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol. 2010;22:21\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"376_CR47","first-page":"309","volume":"29","author":"NI Abdou","year":"2002","unstructured":"Abdou NI, Kullman GJ, Hoffman GS, Sharp GC, Specks U, McDonald T, et al. Wegener\u2019s granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J Rheumatol. 2002;29:309\u201316.","journal-title":"J Rheumatol"},{"key":"376_CR48","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/lary.23273","volume":"122","author":"SC Taylor","year":"2012","unstructured":"Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS. Progression and management of Wegener\u2019s granulomatosis in the head and neck. Laryngoscope. 2012;122:1695\u2013700.","journal-title":"Laryngoscope"},{"key":"376_CR49","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3899\/jrheum.090387","volume":"37","author":"S Kamali","year":"2010","unstructured":"Kamali S, Erer B, Artim-Esen B, Gul A, Ocal L, Konice M, et al. Predictors of damage and survival in patients with Wegener\u2019s granulomatosis: analysis of 50 patients. J Rheumatol. 2010;37:374\u20138.","journal-title":"J Rheumatol"},{"key":"376_CR50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/ard.2009.122952","volume":"70","author":"R Suppiah","year":"2011","unstructured":"Suppiah R, Flossman O, Mukhtyar C, Alberici F, Baslund B, Brown D, et al. Measurement of damage in systemic vasculitis: a comparison of the Vasculitis damage index with the combined damage assessment index. Ann Rheum Dis. 2011;70:80\u20135.","journal-title":"Ann Rheum Dis"},{"key":"376_CR51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00405-010-1421-x","volume":"268","author":"M Martinez Del Pero","year":"2011","unstructured":"Martinez Del Pero M, Walsh M, Luqmani R, Flossmann O, Mukhtyar C, Jani P, et al. Long-term damage to the ENT system in Wegener\u2019s granulomatosis. Eur Arch Otorhinolaryngol. 2011;268:733\u20139.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"376_CR52","first-page":"w13541","volume":"142","author":"C Pagnoux","year":"2012","unstructured":"Pagnoux C, Wolter NE. Vasculitis of the upper airways. Swiss Med Wkly. 2012;142:w13541.","journal-title":"Swiss Med Wkly"},{"key":"376_CR53","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/acr.21565","volume":"64","author":"NM Fowler","year":"2012","unstructured":"Fowler NM, Beach JM, Krakovitz P, Spalding SJ. Airway manifestations in childhood granulomatosis with polyangiitis (Wegener\u2019s). Arthritis Care Res. 2012;64:434\u201340.","journal-title":"Arthritis Care Res"},{"key":"376_CR54","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/lary.22367","volume":"121","author":"JL Wester","year":"2011","unstructured":"Wester JL, Clayburgh DR, Stott WJ, Schindler JS, Andersen PE, Gross ND. Airway reconstruction in Wegener\u2019s granulomatosis-associated laryngotracheal stenosis. Laryngoscope. 2011;121:2566\u201371.","journal-title":"Laryngoscope"},{"key":"376_CR55","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/00016489.2012.674213","volume":"132","author":"J Arebro","year":"2012","unstructured":"Arebro J, Henriksson G, Macchiarini P, Juto JE. New treatment of subglottic stenosis due to Wegener\u2019s granulomatosis. Acta Otolaryngol. 2012;132:995\u20131001.","journal-title":"Acta Otolaryngol"},{"key":"376_CR56","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/rheumatology\/kes382","volume":"52","author":"JU Holle","year":"2013","unstructured":"\u2022 Holle JU, Voigt C, Both M, Holl-Ulrich K, N\u00f6lle B, Laudien M, et al. Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage. Rheumatology. 2013;52:875\u201382. This study characterizes orbital masses as a rare but resistant granulomatous manifestation in a large cohort of GPA patients.","journal-title":"Rheumatology"},{"key":"376_CR57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","volume":"42","author":"PR Rothschild","year":"2013","unstructured":"Rothschild PR, Pagnoux C, Seror R, Br\u00e9zin AP, Delair E, Guillevin L. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum. 2013;42:507\u201314.","journal-title":"Semin Arthritis Rheum"},{"key":"376_CR58","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-4486.2009.01968.x","volume":"34","author":"M Martinez Del Pero","year":"2009","unstructured":"Martinez Del Pero M, Chaudhry A, Jones RB, Sivasothy P, Jani P, Jayne D. B-cell depletion with rituximab for refractory head and neck Wegener\u2019s granulomatosis: a cohort study. Clin Otolaryngol. 2009;34:328\u201335.","journal-title":"Clin Otolaryngol"},{"key":"376_CR59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3899\/jrheum.110143","volume":"39","author":"C Roubaud-Baudron","year":"2012","unstructured":"Roubaud-Baudron C, Pagnoux C, M\u00e9aux-Ruault N, Grasland A, Zoulim A, LE Guen J, et al. Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis. J Rheumatol. 2012;39:125\u201330.","journal-title":"J Rheumatol"},{"key":"376_CR60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","volume":"71","author":"JU Holle","year":"2012","unstructured":"Holle JU, Dubrau C, Herlyn K, Heller M, Ambrosch P, Noelle B, et al. Rituximab for refractory granulomatosis with polyangiitis (Wegener\u2019s granulomatosis: comparison of efficacy in granulomatous versus vasculitic manifestations. Ann Rheum Dis. 2012;71:327\u201333.","journal-title":"Ann Rheum Dis"},{"key":"376_CR61","first-page":"S22","volume":"30","author":"U Garske","year":"2012","unstructured":"Garske U, Haack A, Beltr\u00e1n O, Flores-Su\u00e1rez LF, Bremer JP, Lamprecht P, et al. Intra- and Inter-rater reliability of endonasal activity estimation in granulomatosis with polyangiitis (Wegener\u2019s). Clin Exp Rheumatol. 2012;30:S22\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"376_CR62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00405-012-2110-8","volume":"270","author":"M Martinez Del Pero","year":"2013","unstructured":"Martinez Del Pero M, Rasmussen N, Chaudhry A, Jani P, Jayne D. Structured clinical assessment of the ear, nose and throat in patients with granulomatosis with polyangiitis (Wegener\u2019s). Eur Arch Otorhinolaryngol. 2013;270:345\u201354.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"376_CR63","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s003300050206","volume":"7","author":"C Muhle","year":"1997","unstructured":"Muhle C, Reinhold-Keller E, Richter C, Duncker G, Beigel A, Brinkmann G, et al. MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener\u2019s granulomatosis. Eur Radiol. 1997;7:566\u201370.","journal-title":"Eur Radiol"},{"key":"376_CR64","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10334-012-0351-6","volume":"26","author":"T Klink","year":"2013","unstructured":"\u2022 Klink T, Holle J, Laudien M, Henes FO, Moosig F, Platzek C, et al. Magnetic resonance imaging in patients with granulomatosis with polyangiitis (Wegener\u2019s) and subglottic stenosis. MAGMA. 2013;26:281\u201390. The study describes the value of magnetic resonance imaging for detection and grading of subglottic stenosis in GPA patients.","journal-title":"MAGMA"},{"key":"376_CR65","doi-asserted-by":"crossref","unstructured":"Lamprecht P, Holl-Ulrich K, Gross WL. Granulomatosis with polyangiitis \u2013 Pathogenesis. In: Ball GV, Fessler SL, Bridges BJ, editors. Oxford Textbook on Rheumatology: Vasculitis, 3rd ed. Oxford: Oxford University Press. 2014. In press.","DOI":"10.1093\/med\/9780199659869.003.0029"},{"key":"376_CR66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2249.2008.03775.x","volume":"154","author":"J Voswinkel","year":"2008","unstructured":"Voswinkel J, Assmann G, Held G, Pitann S, Gross WL, Holl-Ulrich K, et al. Single cell analysis of B lymphocytes from Wegener\u2019s granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions. Clin Exp Immunol. 2008;154:339\u201345.","journal-title":"Clin Exp Immunol"},{"key":"376_CR67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaut.2010.09.002","volume":"36","author":"L Thurner","year":"2011","unstructured":"Thurner L, M\u00fcller A, C\u00e9rutti M, Martin T, Pasquali JL, Gross WL, et al. Wegener\u2019s granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin. J Autoimmun. 2011;36:87\u201390.","journal-title":"J Autoimmun"},{"key":"376_CR68","doi-asserted-by":"crossref","unstructured":"Voswinkel J, Mueller A, Kraemer JA, Lamprecht P, Herlyn K, Holl-Ulrich K, et al. B lymphocyte maturation in Wegener\u2019s granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis. 2006;65:859\u201364.","DOI":"10.1136\/ard.2005.044909"},{"key":"376_CR69","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/rheumatology\/kes123","volume":"51","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Odell E, Choong LM, Barone F, Fields P, Wilkins B, et al. Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factor and autoantigen. Rheumatology. 2012;51:1580\u20136.","journal-title":"Rheumatology"},{"key":"376_CR70","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/rheumatology\/ken202","volume":"47","author":"A Mueller","year":"2008","unstructured":"Mueller A, Holl-Ulrich K, Lamprecht P, Gross WL. Germinal centre-like structures in Wegener\u2019s granuloma: the morphological basis for autoimmunity? Rheumatology. 2008;47:1111\u20133.","journal-title":"Rheumatology"},{"key":"376_CR71","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/mi.2011.9","volume":"4","author":"M Laudien","year":"2011","unstructured":"Laudien M, H\u00e4sler R, Wohlers J, B\u00f6ck J, Lipinski S, Bremer L, et al. Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener\u2019s granulomatosis. Mucosal Immunol. 2011;4:564\u201373.","journal-title":"Mucosal Immunol"},{"key":"376_CR72","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.ajpath.2012.01.021","volume":"180","author":"N Kesel","year":"2012","unstructured":"\u2022 Kesel N, K\u00f6hler D, Herich L, Laudien M, Holl-Ulrich K, J\u00fcngel A, et al. Cartilage destruction in granulomatosis with polyangiitis (Wegener\u2019s granulomatosis) is mediated by human fibroblasts after transplantation into immunodeficient mice. Am J Pathol. 2012;180:2144\u201355. This study identifies fibroblasts in nasal mucosa as cellular mediators of cartilage and\/or bone destruction and thus suggests a direct link between granulomatous inflammation and destruction in GPA.","journal-title":"Am J Pathol"},{"key":"376_CR73","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJMicm040881","volume":"352","author":"PM Aries","year":"2005","unstructured":"Aries PM, Both M. Destructive eye lesions in Wegener\u2019s granulomatosis. N Engl J Med. 2005;352:392.","journal-title":"N Engl J Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0376-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-013-0376-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0376-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T19:18:52Z","timestamp":1564168732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-013-0376-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,29]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["376"],"URL":"https:\/\/doi.org\/10.1007\/s11926-013-0376-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,29]]},"article-number":"376"}}